Expanded Access Use of Itacitinib to Treat a Single Patient With STAT1 Gain of Function (GOF) Disease

Sponsor
Incyte Corporation
Study ID
NCT05561985
Status
Available

Conditions

  • STAT1 Gain-of-Function Disease

Eligibility Criteria

Sex
All
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

Expanded access use of Itacitinib to treat a single patient with aplastic anemia.

Key Dates

Status verified
Jun 2026

Central Contacts